Skip to main content
. 2023 Jan 11;16(2):153–164. doi: 10.1007/s40271-022-00614-7

Table 2.

Demographic characteristics of participants

Parameter N = 219
Country, n (%)
 UK 18 (8.2%)
 Ireland 22 (10.0%)
 Germany 71 (32.4%)
 Austria 3 (1.4%)
 Belgium 4 (1.8%)
 The Netherlands 68 (31.1%)
 Denmark 12 (5.5%)
 Switzerland 16 (7.3%)
 Other 5 (2.3%)
Sex, n (%)
 Female 198 (90.4%)
Age (years), n (%)
 ≤ 30 49 (22.4%)
 31–40 78 (35.6%)
 41–50 64 (29.2%)
 > 50 28 (12.8%)
Race, n (%)
 White or Caucasian 205 (93.6%)
 Asian 3 (1.4%)
 Black or African American 0
 Other 11 (5.0%)
Occupational status, n (%)
 Full time employed 87 (39.7%)
 Part time employed 51 (23.3%)
 Student 10 (4.6%)
 Not working or unemployed 31 (14.2%)
 Retired 40 (18.3%)
Highest level of education, n (%)
 Primary or elementary school 7 (3.2%)
 Secondary or high school 120 (54.8%)
 College or university degree 73 (33.3%)
 Other 19 (8.7%)
Disease duration, (years), mean (SD) 10.70 (9.8)
Disease duration, n (%)
 0–3 66 (30.1%)
 4–10 69 (31.5%)
 11–20 51 (23.3%)
 > 20 33 (15.1%)
Severity of HS (by Hurley classification)
 Mild 13 (5.9%)
 Moderate 132 (60.3%)
 Severe 74 (33.8%)
Treatment experience
 Previous biologic therapy 65 (29.7%)
 Previous wide excisional surgery 134 (61.2%)
Level of pain (0–10 VAS), median (IQR) 5 3-7
HiSQOL score, median (SD)
 Total score 34 (16.1)
 Symptom subscale 8 (4.1)
 Psychosocial subscale 10 (5.5)
 Activities and adaptations subscale 17 (8.1)
EQ-5D-5L, mean (SD)
 Mobility 2.14 (1)
 Self-care 1.50 (0.7)
 Usual activities 2.21 (0.9)
 Pain and discomfort 2.94 (1)
 Anxiety and depression 2.58 (1.2)

EQ-5D-5L EuroQoL 5-Dimension-5 Level Questionnaire, HiSQOL Hidradenitis Suppurativa Quality of Life Questionnaire, HS hidradenitis suppurativa, IQR interquartile range, SD standard deviation, VAS Visual Analog Scale